Reaction
Autoimmune Nephritis reporting signals
As of the last recalculation, Autoimmune Nephritis appears in 215 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is IPILIMUMAB (PRR 134.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ipilimumab | 47 | 134.6 | 134.8 |
| Nivolumab | 79 | 124.5 | 124.6 |
| Loperamide Hydrochloride Oral | 7 | 68.6 | 68.6 |
| Pembrolizumab | 52 | 62.8 | 62.8 |
| Pemetrexed | 12 | 57.3 | 57.4 |
| Durvalumab | 11 | 55.1 | 55.1 |
| Pemetrexed Disodium | 16 | 43.8 | 43.9 |
| Atezolizumab | 16 | 43.0 | 43.0 |